Taro Pharmaceutical, a subsidiary of Sun Pharmaceutical, has initiated a recall of over 17,000 units of an antifungal shampoo ...

Mumbai: The Bombay High Court has set aside the interim injunction granted earlier in the trademark infringement and ...

Sun Pharmaceutical Industries targets mid- to high-single digit topline growth in FY26, focusing on innovative medicines and ...

Sun Pharma Dividend 2025: Sun Pharma, the pharma company, is set to trade ex-date and record date on February 6, 2025. The state-run company announced a 1,050 per cent dividend payment on each stock ...

Sun Pharmaceutical Industries Ltd. closed 4.67% below its 52-week high of 1,869.75 rupees, which the company reached on ...

Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US ...

Sun Pharma’s focus areas involve investing in research and development (R&D) to further build its pipeline of innovative medicines.

PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma ...

Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth ...

Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to ...

Sun Pharma highlights obesity treatment drugs as a growth driver for India's pharma industry, enhancing access to GLP-1 ...